Iovance Biotherapeutics

iovance.com

Iovance Biotherapeutics is pioneering a transformational approach to treating cancer by harnessing the human immune system to recognize and attack diverse cancer cells. The company focuses on tumor infiltrating lymphocyte (TIL) therapy, which involves collecting a patient’s TIL, growing them outside the body, and then administering them back to the patient as a one-time treatment. This personalized therapy aims to target various cancer cells unique to each patient, with ongoing clinical studies in multiple advanced solid tumor cancers. Iovance is committed to continuous innovation in cell therapy, including next-generation genetically modified TIL therapies, positioning itself as a leader in the cancer treatment market.